The clinical utility of comprehensive genomic profiling tests for patients with advanced malignant melanoma in a real-world setting: A retrospective analysis from a single cancer center
Y. Matsui,
D. Ogata,
Y. Nakayama,
S. Wada,
S. Tsuruta,
E. Nakano,
K. Namikawa,
H. Uhara,
N. Yamazaki
Affiliations
Y. Matsui
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan; Sapporo Medical University School of Medicine, Department of Dermatology, Sapporo, Japan
D. Ogata
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
Y. Nakayama
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
S. Wada
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
S. Tsuruta
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
E. Nakano
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
K. Namikawa
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
H. Uhara
Sapporo Medical University School of Medicine, Department of Dermatology, Sapporo, Japan
N. Yamazaki
National Cancer Center Hospital, Department of Dermatologic Oncology, Tokyo, Japan
